|
Título:
|
Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The
|
|
Autores:
|
Mallma, Patricia ;
Garcia, Patricia ;
Carcamo, Cesar ;
Torres-Rueda, Sergio ;
Peeling, Rosanna ;
Mabey, David ;
Terris-Prestholt, Fern
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
Public Library of Science, 2019-02-06T14:45:55Z
|
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
|
Idiomas:
|
Inglés
|
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
|
Resumen:
|
Studies have addressed cost-effectiveness of syphilis testing of pregnant women in high-prevalence settings. This study compares costs of rapid syphilis testing (RST) with laboratory-based rapid plasma reagin (RPR) tests in low-prevalence settings in Peru. The RST was introduced in a tertiary-level maternity hospital and in the Ventanilla Network of primary health centers, where syphilis prevalence is approximately 1%. The costs per woman tested and treated with RST at the hospital were $2.70 and $369 respectively compared with $3.60 and $740 for RPR. For the Ventanilla Network the costs per woman tested and treated with RST were $3.19 and $295 respectively compared with $5.55 and $1454 for RPR. The cost per DALY averted using RST was $46 vs. $109 for RPR. RST showed lower costs compared to the WHO standard costs per DALY ($64). Findings suggest syphilis screening with RST is cost-effective in low-prevalence settings.
|
|
En línea:
|
http://doi.org/10.1371/journal.pone.0149568
|
